Recent studies demonstrated that hepatic TNFRSF12A was markedly increased in NASH, alcoholic liver disease, chronic hepatitis C, and hepatocellular carcinoma [20, 21]. The gene discussed is TNFRSF12A; the disease is metabolic dysfunction-associated steatohepatitis.